Emma Grace is currently pursuing her bachelor's degree at University of South Carolina. Her summer research project focused on bi-specific antibody drug combinations in multiple myeloma.
Lauren left the lab in Spring 2023 after working with us for 3 years. During her time in the lab, Lauren optimized and expanded our drug sensitivity assay My-DST. She also investigated when relapse myeloma patients can be re-treated with the CD38 monoclonal antibody therapy Daratumumab. Lauren is currently attending medical school at the University of Southern California - Los Angeles.
Olivia Perez de Acha Lopez comes to us from Madrid, Spain. She recently received her MD from Universidad Autonoma de Madrid. Her past research was done at the Hospital Puerta de Hierro studying TKI drug resistance in liquid biopsies from patients with EGFR+ lung adenocarcinoma. Before joining us at CU, Olivia also spent last summer at the NIH studying exosomes as potential biomarkers in Alzheimer's Disease. In our group, she evaluated immunotherapy targets, with a particular focus on the daratumumab-refractory setting. In 2021 Olivia matched for medical residency in Washington D.C.
Beau left the lab in
June 2020 after working with us for 1 ½ years. During his time in our lab, Beau
pioneered our pipeline for testing drug combinations for synergy in cell lines
and patient samples. He also made significant contributions to multiple
projects through ex vivo drug sensitivity experiments and testing new potential
myeloma regimens using in vivo xenograft models. Beau is currently pursuing his MD at the Mayo Clinic in Scottsdale Arizona.
Denis left the lab in June 2020 after working with us for 1 year. During his time with our group, Denis created a bioinformatics pipeline for processing mass cytometry (CyTOF) data in Rstudio, and analyzing the output via machine learning algorithms. He also conducted our first single cell RNA sequencing experiment to interrogate myeloma subpopulations. After leaving the lab, Denis entered the MD, PhD program at Emory University.
American Society of Hematology Annual meeting, San Diego, 2018
Mount Bierstadt Summit, 14,065 feet